Index Option Calls
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Index Option Calls
No Result
View All Result
Home Latest News

Altria can’t sell Iqos in the U.S. as Biden administration opts to not intervene in patent dispute

by
November 30, 2021
in Latest News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

ChatGPT is ‘down all the time’ and people keep using it. What that says to Google alum Elad Gil about bad Silicon Valley advice

You’ll Only Have This Much Social Security Left After Paying Medical Bills in Retirement

Philip Morris International shows an iQOS electronic cigarette, which heats tobacco sticks but does not burn them.

Fabrice Coffrini | AFP | Getty Images

Altria and Philip Morris International are no longer able to sell or import Iqos tobacco devices in the U.S. after the Biden administration opted to take no action on an ongoing patent dispute.

Rival R.J. Reynolds, a subsidiary of British American Tobacco, had filed a claim with the U.S. International Trade Commission. In late September, the ITC ruled that the Iqos device infringed on two of Reynolds’ patents. As part of the process, the Biden administration conducted a 60-day administrative review and decided to not take any action to reverse the ITC’s decision.

“Today’s announcement provides a measure of success for our enforcement of IP rights to ensure we can continue to innovate, as is common practice among innovation-based industries,” British American Tobacco Assistant General Counsel Gareth Cooper said in a statement.

Altria launched the Iqos device in the United States two years ago, but it began development of the product more than a decade ago before Philip Morris was spun off from the company. The device heats tobacco without burning it, which is meant to give users the same rush of nicotine without as many toxins as smoking a cigarette.

Philip Morris sells the device in dozens of international markets and has granted Altria a license to sell it in the U.S. While Iqos doesn’t represent a large portion of Altria’s U.S. business, it’s part of the company’s shift away from traditional tobacco products, which have seen falling demand. Altria said it counts 20,000 U.S. consumers as users of the device, but they will no longer be able to purchase it in the U.S.

This isn’t the end of the patent dispute between Reynolds, Altria and Philip Morris. Reynolds also filed a claim with the U.S. Patent and Trademark Office over Iqos. That process is expected to take six to 12 months, although decisions can be appealed, which could drag it out even longer.

“While this decision will cause near-term disruption, we continue to see a large opportunity for IQOS and other FDA authorized smoke-free products in the U.S. over the coming years,” Philip Morris said in a statement.

Philip Morris also said that its contingency plans to return to the U.S. are underway. The two companies could move production to the U.S. or change up the design enough to avoid patent infringement claims.

Shares of British American Tobacco were down 1% in premarket trading on Tuesday, while the stocks of Altria and Philip Morris had both fallen less than 1%.

ShareTweetPin

Related Posts

ChatGPT is ‘down all the time’ and people keep using it. What that says to Google alum Elad Gil about bad Silicon Valley advice

by
January 30, 2023
0

S&P Futures 4,079.00 -5.25(-0.13%)   Dow Futures 34,002.00 -44.00(-0.13%)   Nasdaq Futures 12,209.50 -12.75(-0.10%)   Russell 2000 Futures 1,916.00 -3.50(-0.18%)...

You’ll Only Have This Much Social Security Left After Paying Medical Bills in Retirement

by
January 30, 2023
0

S&P Futures 4,073.00 -11.25(-0.28%)   Dow Futures 33,973.00 -73.00(-0.21%)   Nasdaq Futures 12,177.50 -44.75(-0.37%)   Russell 2000 Futures 1,913.50 -6.00(-0.31%)...

Wall Street says Europe’s a better bet than the U.S. right now — and names its top stock picks

by
January 30, 2023
0

European stocks are are having a good year so far. The benchmark Stoxx 600 is up around 7% since the...

Adani’s $2.5 billion share sale faces crucial day after rout

by
January 30, 2023
0

In this article ADANIENT-IN Follow your favorite stocksCREATE FREE ACCOUNT People walk past an electronic sign displaying news on the...

Goldman Sachs names tech stocks with a ‘strong runway’ for growth — giving one upside of nearly 70%

by
January 30, 2023
0

One corner of tech, software, might be seeing "limited appetite" from the market, according to Goldman Sachs. But the investment...

Next Post

Google pulls the plug on e-commerce giant Wish in France for listing unsafe goods

Dow futures are down 300 points as investors try to gauge the economic impact of omicron

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • A Couple Stored IRA Gold at Home. They Owe the IRS More Than $300,000.

    0 shares
    Share 0 Tweet 0
  • A California Couple Spent Eight Years Building Their Dream Retirement Home in Costa Rica

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs says buy these stocks to play Web 3.0 and the metaverse

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs picks new stocks to buy — and says these 5 have over 100% upside

    0 shares
    Share 0 Tweet 0
  • In his final warning, this stock trading wizard — who made big money in bear markets and crashes — called this market a bubble like no other

    0 shares
    Share 0 Tweet 0
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.indexoptioncalls.com
No Result
View All Result
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.indexoptioncalls.com